top of page
Executive Spotlights

Guillaume Pfefer, Ph.D., MBA, will become Sail's CEO

Cambridge, MA, October 19, 2023 (PRNewswire) -- Flagship Pioneering merges Laronde and Senda Biosciences to create Sail Biomedicines. Dr. Guillaume Pfefer, CEO-Partner at Flagship Pioneering, will lead Sail Biomedicines as CEO and board member, focusing on the innovation of fully programmable medicines to advance patient care.

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page